These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19532999)

  • 1. A straightforward microwave method for rapid synthesis of N-1, C-6 functionalized 3,5-dichloro-2(1H)-pyrazinones.
    Gising J; Ortqvist P; Sandström A; Larhed M
    Org Biomol Chem; 2009 Jul; 7(13):2809-15. PubMed ID: 19532999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of achiral inhibitors of the hepatitis C virus NS3 protease based on 2(1H)-pyrazinones.
    Ortqvist P; Gising J; Ehrenberg AE; Vema A; Borg A; Karlén A; Larhed M; Danielson UH; Sandström A
    Bioorg Med Chem; 2010 Sep; 18(17):6512-25. PubMed ID: 20673728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Easy-to-execute carbonylations: microwave synthesis of acyl sulfonamides using Mo(CO)(6) as a solid carbon monoxide source.
    Wu X; Rönn R; Gossas T; Larhed M
    J Org Chem; 2005 Apr; 70(8):3094-8. PubMed ID: 15822969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-phase synthesis of the 2(1H)-pyrazinone scaffold: a new approach toward diversely substituted heterocycles.
    Kaval N; Dehaen W; Van der Eycken E
    J Comb Chem; 2005; 7(1):90-5. PubMed ID: 15638486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of "click chemistry" for the decoration of 2(1H)-pyrazinone scaffold: generation of templates.
    Kaval N; Ermolat'ev D; Appukkuttan P; Dehaen W; Kappe CO; Van der Eycken E
    J Comb Chem; 2005; 7(3):490-502. PubMed ID: 15877478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure-activity relationship at the C-terminal position.
    Rancourt J; Cameron DR; Gorys V; Lamarre D; Poirier M; Thibeault D; Llinàs-Brunet M
    J Med Chem; 2004 May; 47(10):2511-22. PubMed ID: 15115394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
    Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety.
    Rönn R; Lampa A; Peterson SD; Gossas T; Akerblom E; Danielson UH; Karlén A; Sandström A
    Bioorg Med Chem; 2008 Mar; 16(6):2955-67. PubMed ID: 18194867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition metal-catalyzed orthogonal solid-phase decoration of the 2(1H)-pyrazinone scaffold using a sulfur linker.
    Kaval N; Singh BK; Ermolat'ev DS; Claerhout S; Parmar VS; der Eycken JV; der Eycken EV
    J Comb Chem; 2007; 9(3):446-53. PubMed ID: 17373850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
    Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
    Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors.
    Belema M; Bunker A; Nguyen VN; Beaulieu F; Ouellet C; Qiu Y; Zhang Y; Martel A; Burke JR; McIntyre KW; Pattoli MA; Daloisio C; Gillooly KM; Clarke WJ; Brassil PJ; Zusi FC; Vyas DM
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4284-9. PubMed ID: 17540562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palladium-catalyzed copper(I)-mediated cross-coupling of arylboronic acids and 2(1H)-pyrazinones facilitated by microwave irradiation with simultaneous cooling.
    Singh BK; Mehta VP; Parmar VS; Van der Eycken E
    Org Biomol Chem; 2007 Sep; 5(18):2962-5. PubMed ID: 17728862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel and versatile entry to asymmetrically substituted pyrazines.
    Mehta VP; Sharma A; Hecke KV; Meervelt LV; Eycken EV
    J Org Chem; 2008 Mar; 73(6):2382-8. PubMed ID: 18284254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-NS3 protease inhibitors of hepatitis C virus based on an R
    Belfrage AK; Abdurakhmanov E; Åkerblom E; Brandt P; Alogheli H; Neyts J; Danielson UH; Sandström A
    Eur J Med Chem; 2018 Mar; 148():453-464. PubMed ID: 29477077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent triazolyl-proline-based inhibitors of HCV NS3 protease.
    Naud J; Lemke C; Goudreau N; Beaulieu E; White PD; Llinàs-Brunet M; Forgione P
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3400-4. PubMed ID: 18448339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolidine-5,5-trans-lactams. 2. The use of X-ray crystal structure data in the optimization of P3 and P4 substituents.
    Andrews DM; Chaignot H; Coomber BA; Good AC; Hind SL; Johnson MR; Jones PS; Mills G; Robinson JE; Skarzynski T; Slater MJ; Somers DO
    Org Lett; 2002 Dec; 4(25):4479-82. PubMed ID: 12465917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New potential inhibitors of cyclin-dependent kinase 4: design and synthesis of pyrido[2,3-d]pyrimidine derivatives under microwave irradiation.
    Tu S; Zhang J; Zhu X; Xu J; Zhang Y; Wang Q; Jia R; Jiang B; Zhang J
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3578-81. PubMed ID: 16621547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening assay of hepatitis C virus helicase inhibitors using fluorescence-quenching phenomenon.
    Tani H; Akimitsu N; Fujita O; Matsuda Y; Miyata R; Tsuneda S; Igarashi M; Sekiguchi Y; Noda N
    Biochem Biophys Res Commun; 2009 Feb; 379(4):1054-9. PubMed ID: 19150342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution and solid-phase synthesis of potent inhibitors of hepatitis C virus NS3 proteinase.
    Beevers R; Carr MG; Jones PS; Jordan S; Kay PB; Lazell RC; Raynham TM
    Bioorg Med Chem Lett; 2002 Feb; 12(4):641-3. PubMed ID: 11844690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of highly functionalized 2(1H)-pyrazinone 3-carboxamide scaffolds.
    Pawar SV; Pawar VG; Dehaen W; De Borggraeve WM
    Org Lett; 2008 Oct; 10(20):4473-6. PubMed ID: 18798637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.